Purdue University’s College of Pharmacy and the Center for Cancer Research are teaming up to help fight breast cancer through the research of Dr. Michael Wendt and Wendt Labs. Research in Wendt Labs is focused on the development of new models that test new therapies for the treatment of metastatic breast cancer. Metastatic breast cancer is described as breast cancer that has spread to other areas of the body, such as lymph nodes. Our emphasis on personalized care allow oncologists to determine which therapies will work for a specific patient’s disease. To do this we engraft patient tumor biopsy material onto recipient mice, and these “avatar” mice are being developed as a platform to test which therapies will work best for a particular patient.
Our goal of $30,000 will allow us to continue to optimize our techniques in creating the avatar mice, and to continue to establish our panel of anti-cancer treatments capable of combating metastatic breast cancer. Driving personalized care in metastatic breast cancer requires a team effort from surgeons to nurses, pathologists to researchers, as well as animal care staff. Wendt Labs has brought all these components together here at Purdue University, but we need financial assistance to support the numerous costs that are associated with biomedical research and personnel. Breast cancer is the most commonly diagnosed cancer in women. In fact, 1 in 8 women will be diagnosed with breast cancer in their lifetime. Help us drive this statistic down.
If you're interested in learning more about making a major gift to this campaign, please contact John Dinkens at 765-494-0501 or JADinkens@prf.org
50% off a ticket to the Purdue Hammer Down Cancer Football game on September 24th, 2016